We validated that the 150 mg/ml ART-loaded TCH group significantly decreased the expression of p38-MAPK and ERK1 and the phosphorylation levels of p38-MAPK and ERK1 when compared with the T2DM group (p < 0.01) (Fig. 7C-E). The gene discussed is MAPK3; the disease is type 2 diabetes mellitus.